DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier-Reference-Cited by-同舟云学术

DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier

Published:2014-07-27 Issue:7520 Volume:514 Page:107-111
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Santos Margarida A.,Faryabi Robert B.,Ergen Aysegul V.,Day Amanda M.,Malhowski Amy,Canela Andres,Onozawa Masahiro,Lee Ji-Eun,Callen Elsa,Gutierrez-Martinez Paula,Chen Hua-Tang,Wong Nancy,Finkel Nadia,Deshpande Aniruddha,Sharrow Susan,Rossi Derrick J.,Ito Keisuke,Ge Kai,Aplan Peter D.,Armstrong Scott A.,Nussenzweig André

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature13483.pdf

Reference40 articles.

1. Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283–296 (2012)

2. Nijnik, A. et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447, 686–690 (2007)

3. Rossi, D. J. et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725–729 (2007)

4. Tothova, Z. et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325–339 (2007)

5. Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011)

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma;Nature Communications;2024-08-08

2. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress;Developmental Cell;2024-08

3. Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage;2024-08-01

4. Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML;Blood;2024-07-04

5. Functions and inhibitors of CHK1 in cancer therapy;Medicine in Drug Discovery;2024-06